Human B7-1/CD80 Protein, Accession: P33681

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human B7-1/CD80 Protein is expressed from HEK293 with hFc tag at the C-terminal.It contains Val35-Asn242.

    Biotinylated

    产物规格

    靶点

    B7-1/CD80

    份子又名

    CD80 molecule; B7; B71; B7-1; BB1; CD28LG1; CD80; B7.1; CD28LG1; LAB7

    Accession

    种属

    Human

    卵白序列

    Val35-Asn242

    份子量

    The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human B7-1, hFc Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Human CTLA-4, His Tag with the EC50 of 0.27ug/ml determined by ELISA. See testing image for detail.

    产物标签

    C-hFc

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该终产物的公司ChemWhat是Watson的注册网站品种，由Watson受权宁波海角社区 在在我国内地地理环境充分利用，点此拜候。